AzTrials
AzTrials

Chronic Low-back Pain (cLBP)ShockEffectNCT05308641

Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients With Chronic Low Back Pain

A study testing radial extracorporeal shockwave therapy_4000_20, radial extracorporeal shockwave therapy_500_2 and standard multimodal pain therapy in people with Chronic Low-back Pain (cLBP), run by Ruhr University of Bochum at 1 site in Germany.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Analysis of the effectiveness of radial shock wave therapy as part of a multimodal pain therapy in the inpatient setting. Different therapy protocols are compared in previously non-operated and in previously operated patients. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Chronic Low-back Pain (cLBP)
What is being tested?
radial extracorporeal shockwave therapy_4000_20, radial extracorporeal shockwave therapy_500_2 and standard multimodal pain therapy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteGermany
Study dates
18 Sep 2022to 7 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • chronic lumbar back pain of min 3 months duration

Who cannot join

  • radicular pain of higher intensity than chronic low back pain (cLBP)
  • new neurologic deficits
  • anticoagulant therapy
  • new trauma to the lumbar spine
  • spine bacterial infection
  • spine tumor
Show all 10Show fewer
  • pregnancy
  • coagulation disorder
  • previous infiltration to the lumbar spine within 6 weeks prior to study inclusion
  • fibromyalgia

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Klinik Blankenstein

    Hattingen, 45527

Other trials in Germany

About this study

Official title: Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients With Chronic Low Back Pain - Randomized Controlled Trial

Analysis of the effectiveness of radial shock wave therapy as part of a multimodal pain therapy in the inpatient setting. Different therapy protocols are compared in previously non-operated and in previously operated patients.

Read the detailed description

Radial shock wave therapy is an approved pain therapy procedure that has been used in various degenerative orthopedic diseases for years. There are a few studies on the subject of chronic back pain. Some studies suggest that this method can be used sensibly. A direct comparison of different therapy protocols has not been carried out so far.

As part of inpatient multimodal pain therapy (including infiltration and physiotherapy) in patients with chronic lumbar back pain with or without degenerative surgery in the area of the lumbar spine radial shock wave therapy after a specific protocol is used. Only inpatients will be admitted to the study. All patients are informed verbally and give their written consent. Comprehensive patient information will be provided before the start of the study, handed out and explained as part of the information discussion. There will be 2 groups ((a) patients with previous degenerative surgery in the area of the lumbar spine, (b) patients without such a pre-operation) examined each with 4 sub-groups depending of the different therapy protocols.

Being tested
radial extracorporeal shockwave therapy_4000_20, radial extracorporeal shockwave therapy_500_2, standard multimodal pain therapy
Keywords
radial shockwave therapy, chronic low back pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • radial extracorporeal shockwave therapy_4000_20Procedure or surgery

    application of radial extracorporeal shockwave therapy (rESWT) with 4000 pulses and 20 Hz

  • radial extracorporeal shockwave therapy_500_2Procedure or surgery

    application of radial extracorporeal shockwave therapy (rESWT) with 500 pulses and 2 Hz

  • standard multimodal pain therapyProcedure or surgery

    standard multimodal pain therapy

Study groups in NCT05308641
Study groupRoleWhat they receive
PreviousSurgery(PrevSurg)_YES/rESWT_4000Active comparatorPrevious Surgery on degenerative pathology in lumbar spine: YES rESWT: 4000 pulse, 20 Hz
Receives: Procedure: radial extracorporeal shockwave therapy_4000_20; Procedure: standard multimodal pain therapy
PrevSurg_YES/rESWT_500Active comparatorPrevious Surgery on degenerative pathology in lumbar spine: YES rESWT: 500 pulse, 2 Hz
Receives: Procedure: radial extracorporeal shockwave therapy_500_2; Procedure: standard multimodal pain therapy
PrevSurg_YES/rESWT_noActive comparatorPrevious Surgery on degenerative pathology in lumbar spine: YES rESWT: no
Receives: Procedure: standard multimodal pain therapy
PrevSurg_YES/rESWT_denyActive comparatorPrevious Surgery on degenerative pathology in lumbar spine: YES rESWT: denied
Receives: Procedure: standard multimodal pain therapy
PrevSurg_NO/rESWT_4000Active comparatorPrevious Surgery on degenerative pathology in lumbar spine: NO rESWT: 4000 pulse, 20 Hz
Receives: Procedure: radial extracorporeal shockwave therapy_4000_20; Procedure: standard multimodal pain therapy
PrevSurg_NO/rESWT_500Active comparatorPrevious Surgery on degenerative pathology in lumbar spine: NO rESWT: 500 pulse, 2 Hz
Receives: Procedure: radial extracorporeal shockwave therapy_500_2; Procedure: standard multimodal pain therapy
PrevSurg_NO/rESWT_noActive comparatorPrevious Surgery on degenerative pathology in lumbar spine: NO rESWT: no
Receives: Procedure: standard multimodal pain therapy
PrevSurg_NO/rESWT_denyActive comparatorPrevious Surgery on degenerative pathology in lumbar spine: NO rESWT: denied
Receives: Procedure: standard multimodal pain therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in Numeric Rating Scale (NRS)

    Pain intensity measured by Numeric Rating Scale (NRS)

    • 11-point scale / min. 0 (better outcome) / max. 10 (worse outcome)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

Secondary outcomes (9)
  1. change in Oswestry Disability Index (ODI)

    Oswestry Disability Index (ODI)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

  2. change in European Quality of Life 5 Dimensions (EQ5D)

    European Quality of Life 5 Dimensions (EQ5D)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

  3. change in Pain Self-Efficacy Questionnaire (PSEQ)

    Pain Self-Efficacy Questionnaire (PSEQ)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

  4. change in Patient Health Questionnaire-9 (PHQ-9)

    Patient Health Questionnaire-9 (PHQ-9)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

  5. change in Perseverative Thinking Questionnaire (PTQ)

    Perseverative Thinking Questionnaire (PTQ)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

  6. change in Patient Specific Functional Scale (PSFS)

    Patient Specific Functional Scale (PSFS)

    • five daily important activities are rated on a 11-point scale
    • min. 0 (worse outcome) / max. 10 (better outcome)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

  7. change in The World Health Organisation- Five Well-Being Index (WHO-5)

    The World Health Organisation- Five Well-Being Index (WHO-5)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

  8. change in Big Five Inventory-SocioOeconomicPanel (BFI-S)

    Big Five Inventory-SocioOeconomicPanel (BFI-S)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

  9. change in Questionnaire Subgroups for Targeted Treatment (STarT-G)

    Subgroups for Targeted Treatment (STarT-G)

    Measured: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2022
  2. Study start18 Sep 2022
  3. Primary completion31 Dec 2024
  4. Study completion7 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05308641
Sponsor's protocol ID
1_1
Acronym
ShockEffect
Status last verified
Apr 2025
First submitted
15 Mar 2022
Last updated
6 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lange T, Deventer N, Gosheger G, Lampe LP, Bockholt S, Schulze Boevingloh A, Schulte TL. Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain-Randomized Controlled Trial. J Clin Med. 2021 Nov 26;10(23):5569. doi: 10.3390/jcm10235569.

    PubMed 34884271

Questions about this trial

What is this clinical trial studying?

A study testing radial extracorporeal shockwave therapy_4000_20, radial extracorporeal shockwave therapy_500_2 and standard multimodal pain therapy in people with Chronic Low-back Pain (cLBP), run by Ruhr University of Bochum at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in Numeric Rating Scale (NRS) (time frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05308641, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in